UCSF Tops Public Universities in NIH Research Funding in 2023 (2024)
UC San Francisco received the most funding from the National Institutes of Health (NIH) of any public university in 2023, driving one of the most diverse portfolios of scientific research in the nation.
It is the 17th year in a row that UCSF has earned this distinction among public institutions.
“Support from the NIH enables our researchers to test their boldest ideas for advancing science, medicine and health, and it is vital for training the next generation of innovators,” said UCSF Chancellor Sam Hawgood, MBBS. “This is a testament to our impact from bench to bedside: from the fundamentals of biology to neurodegeneration, cancer and infectious disease.”
UCSF’s total funding of $789,196,651 ranked second among all public and private U.S. universities, after Johns Hopkins University. Leidos Biomedical Research, Inc., which administers research contracts for the National Cancer Institute’s Frederick National Laboratory, was the largest recipient overall, receiving $866 million.
The funds are spread across 1,484 grants to trainees, research staff and faculty in the Schools of Medicine, Pharmacy, Dentistry and Nursing, as well as the Graduate Division. They support a wide array of research, from basic and translational sciences to social and population health, as well as education.
UCSF’s Schools of Dentistry, Medicine and Pharmacy were first among their national peers, and the School of Nursing was first among public nursing schools and third overall.
The School of Medicine received $700 million in funding. The School of Pharmacy, the top school in its field for 44 years, received $37 million. The School of Dentistry received $27 million. And the School of Nursing received $19 million.
These public research funds lay a foundation for a healthier future for everyone.”
The Graduate Division received more than $32 million in training grants, the largest amount given to a public institution, and the third highest overall. These funds support the division’s 20 science and social science doctoral programs, 13 science and health master’s programs, two professional doctorates, and over 1,000 post-doctoral scholars.
Combined with UCSF’s Discovery Fellows Program, these NIH grants ensure that all first- and second-year basic and biomedical science PhD students at UCSF receive full financial support.
“These public research funds lay a foundation for a healthier future for everyone,” said Catherine Lucey, MD, executive vice chancellor and provost at UCSF. “NIH funding bolsters everything from the discoveries occurring right now in UCSF laboratories to educational programs for our trainees who will face tomorrow’s biomedical challenges.”
UC San Francisco received the most funding from the National Institutes of Health (NIH) of any public university in 2023, driving one of the most diverse portfolios of scientific research in the nation. It is the 17th year in a row that UCSF has earned this distinction among public institutions.
From 2014 to 2018, the NIH budget increased every year, and yet, the Research Project Grant (RPG) success rate remained relatively constant at ~20%. From 2003 to 2006 the NIH budget remained relatively flat, yet the success rate decreased dramatically from 30% to 20%.
In 2019, the NIH was ranked number two in the world, behind Harvard University, for biomedical sciences in the Nature Index, which measured the largest contributors to papers published in a subset of leading journals from 2015 to 2018.
Rankings. University of California San Francisco is ranked #16 in Best Global Universities. Schools are ranked according to their performance across a set of widely accepted indicators of excellence.
For experienced investigators, applications with Impact scores 30 or better are the most likely to be funded. For Early Stage Investigators and New Investigators seeking their first R01 research grant, and for K award applicants, applications with Impact scores of 35 or better will be considered for funding.
NIH is a medical research organization. As such, we only enroll patients who are participating in one of our clinical studies. These trials span a wide range of diseases and conditions.
The Simplified Framework for NIH Peer Review initiative reorganizes the five regulatory criteria (Significance, Investigators, Innovation, Approach, Environment; 42 C.F.R. Part 52h.
As the largest public funder of biomedical and behavioral research in the world, NIH is the driving force behind decades of advances that improve health, revolutionize science, and serve society more broadly.
The direct salary for individuals under NIH grant and cooperative agreement awards cannot exceed “Executive Level II” of the Federal Executive pay scale. Effective January 1, 2024, the salary limitation for Executive Level II is $221,900. The previous cap was $212,100.
We are home to five Nobel laureates who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Our hospitals and educational programs consistently rank among the best in the country, according to the latest surveys by U.S. News & World Report.
University of California, San Francisco is the leading university exclusively focused on health. Through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care, UCSF is leading revolutions in health worldwide.
We are a national leader in clinical care, education, and research in the field of hospital medicine. Our division has achieved a remarkable number of "firsts" in hospital medicine, including coining the term "hospitalist" in 1996.
The most popular majors at University of San Francisco include: Business, Management, Marketing, and Related Support Services; Health Professions and Related Programs; Social Sciences; Psychology; Biological and Biomedical Sciences; Computer and Information Sciences and Support Services; Parks, Recreation, Leisure, ...
Introduction: My name is Greg Kuvalis, I am a witty, spotless, beautiful, charming, delightful, thankful, beautiful person who loves writing and wants to share my knowledge and understanding with you.
We notice you're using an ad blocker
Without advertising income, we can't keep making this site awesome for you.
